9-Oxononanoic Acid
(Synonyms: 9-氧代壬酸) 目录号 : GC46761An oxidized fatty acid
Cas No.:2553-17-5
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
9-Oxononanoic acid is an oxidized fatty acid formed via the autoxidation of linoleic acid .1,2 It increases phospholipase A2 (PLA2) activity and production of thromboxane B2 in isolated human plasma.1 9-Oxononanoic acid decreases hepatic de novo fatty acid synthesis and increases hepatic carnitine palmitoyltransferase activity, a marker of β-oxidation, in rats.2
1.Ren, R.F., Hashimoto, T., Mizuno, M., et al.A lipid peroxidation product 9-oxononanoic acid induces phospholipase A2 activity and thromboxane A2 production in human bloodJ. Clin. Biochem. Nutr.52(3)228-233(2013) 2.Minamoto, S., Kanazawa, K., Ashida, H., et al.Effect of orally administered 9-oxononanoic acid on lipogenesis in rat liverBiochim. Biophys. Acta958(2)199-204(1988)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 5.8072 mL | 29.036 mL | 58.072 mL |
5 mM | 1.1614 mL | 5.8072 mL | 11.6144 mL |
10 mM | 0.5807 mL | 2.9036 mL | 5.8072 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。